Evidence map›Paper›PMID 42466757›Full record

ReviewCell proliferation2026

Targeting m

Lida Du, Joshua S Fleishman, Shuang Wu, Yuan Zhou, Clara X Wang, Haitong Wang, Yumin Wang, Hongquan Wang

Abstract readReview
In one paragraph

Review in Cell proliferation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lida DuDivision of Neurobiology, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-8598-6224
Joshua S FleishmanDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, USA.ORCID https://orcid.org/0000-0003-1092-6272
Shuang WuDepartment of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yuan ZhouDivision of Neurobiology, Johns Hopkins University, Baltimore, Maryland, USA.
Clara X WangSchool of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Haitong WangDivision of Neurobiology, Johns Hopkins University, Baltimore, Maryland, USA.
Yumin WangDepartment of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.ORCID https://orcid.org/0000-0001-7023-7159
Hongquan WangDepartment of Geriatrics, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing, China.

Funding

Beijing Natural Science Foundation 7252174Grant of Chinese Medicine Education Association MBRC0012025011Grant of Chinese Medicine Education Association MBRC0012025029National Natural Science Foundation of China 82505717Science Foundation of AMHT 2022YK01Science Foundation of AMHT 2022YK27Science Foundation of AMHT 2024YK04Science Foundation of AMHT 2024YK05Science Foundation of ASCH YN202305Science Foundation of ASCH YN202402Science Foundation of ASCH YN202423Wu Jieping Medical Foundation 320.6750.2024-13-59
6 · The paper itself

Abstract

Ferroptosis, a regulated form of cell death driven by iron-dependent lipid peroxidation, emerged as a critical process in the pathogenesis of various diseases, including neurological, cardiovascular, hepatic, pulmonary, and renal disorders. Simultaneously, N6-methyladenosine (m

Indexed as

AdenosineFerroptosisAnimalsEpitranscriptomeHumansRNA MethylationAdenosineN-methyladenosinediseasesepigenetic modificationsferroptosisN6‐methyladenosine

Identifiers

PMID42466757
PMCPMC13378040

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.